Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks

References

• US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Guidance for Industry SUPAC-MR: modified release solid oral dosage forms scale-up and postapproval changes; chemistry, manufacturing, and controls; in vitro dissolution testing and in vivo bioequivalence documentation Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070640.pdf Accessed February 17, 2013
   Google Scholar
• Emami J In vitro-in vivo correlation: from theory to applications J Pharm Sci 2006 9 169 189
   Web of Science ®Google Scholar
• Polli JE IVIVR versus IVIVC Available from: http://www.dissolution-tech.com/DTresour/800Articles/800_art1.html Accessed February 17, 2013
   Google Scholar
• Żurada JM Introduction to Artificial Neural Systems St Paul, MN West Publishing Company 1992
   Google Scholar
• Chen Y McCall TW Baichwal AR Meyer MC The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms J Control Release 1999 59 33 41 10210720
   PubMed Web of Science ®Google Scholar
• Bourquin J Shmidli H van Hoogevest P Leuenberger H Advantages of artificial neural networks (ANNs) as alternative modeling technique for data sets showing non-linear relationship using data from a galenical study on a solid dosage form Eur J Pharm Sci 1998 7 5 16 9845773
   PubMed Web of Science ®Google Scholar
• Mendyk A Jachowicz R Neural network as a decision support system in the development of pharmaceutical formulation – focus on solid dispersions Expert Syst Appl 2005 28 285 294
   Web of Science ®Google Scholar
• Mitra A Wu Y Use of in vitro-in vivo correlation (IVIVC) to facilitate the development of polymer-based controlled release injectable formulations Recent Pat Drug Deliv Formul 2010 4 94 104 20214657
   PubMedGoogle Scholar
• Türkoğlu M Özarslan R Sakr A Artificial neural network analysis of a direct compression tabletting study Eur J Pharm Biopharm 1995 41 315 322
   Web of Science ®Google Scholar
• Rocksloh K Rapp FR Abed Abu S Optimization of crushing strength and disintegration time of a high-dose plant extract tablet by neural networks Drug Dev Ind Pharm 1999 25 1015 1025 10518241
   PubMed Web of Science ®Google Scholar
• Belic A Skrjanc I Bozic DZ Karba R Vrecer F Minimisation of the capping tendency by tableting process optimisation with the application of artificial neural networks and fuzzy models Eur J Pharm Biopharm 2009 73 172 178 19465122
   PubMed Web of Science ®Google Scholar
• Brier ME Żurada JM Neural network predicted peak and trough gentamicin concentrations Pharm Res 1995 12 406 412 7617529
   PubMed Web of Science ®Google Scholar
• Chow HH Tolle KM Roe DJ Elsberry V Chen H Application of neural networks to population pharmacokinetic data analysis J Pharm Sci 1997 86 840 845 9232526
   PubMed Web of Science ®Google Scholar
• Opara J Primozic S Cvelbar P Prediction of pharmacokinetic parameters and the assessment of their variability in bioequivalence studies by artificial neural networks Pharm Res 1999 16 944 948 10397618
   PubMed Web of Science ®Google Scholar
• Yamamura S Kawada K Takehira R Artificial neural network modeling to predict the plasma concentration of aminoglycosides in burn patients Biomed Pharmacother 2004 58 239 244 15183849
   PubMed Web of Science ®Google Scholar
• Agatonovic-Kustrin S Turner JV Glass BD Quantitative structure-retention-pharmacokinetic relationship studies Drug Metab Lett 2008 2 130 137 19356082
   PubMedGoogle Scholar
• Poynton MR Choi BM Kim YM Machine learning methods applied to pharmacokinetic modelling of remifentanil in healthy volunteers: a multi-method comparison J Int Med Res 2009 37 1680 1691 20146865
   PubMed Web of Science ®Google Scholar
• De Matas M Shao Q Silkstone VL Chrystyn H Evaluation of an in vitro in vivo correlation for nebulizer delivery using artificial neural networks J Pharm Sci 2007 96 3293 3303 17630647
   PubMed Web of Science ®Google Scholar
• Dowell J Hussain A Devane J Young D Artificial neural networks applied to the in vitro-in vivo correlation of an extended-release formulation: initial trials and experience J Pharm Sci 1999 88 154 160 9874718
   PubMed Web of Science ®Google Scholar
• Parojčić J Ibrić S Djurić Z Jovanović M Corrigan OI An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation Eur J Pharm Sci 2007 30 264 272 17188851
   PubMed Web of Science ®Google Scholar
• Fatouros DG Nielsen FS Douroumis D Hadjileontiadis LJ Mullertz A In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks Eur J Pharm Biopharm 2008 69 887 898 18367386
   PubMed Web of Science ®Google Scholar
• ChemAxon. [homepage on the Internet] ChemAxon company Available from: http://www.chemaxon.com Accessed December 6, 2012
   Google Scholar
• Bilski J The back-propagation learning with logarithmic transfer function Abstract presented at the Fifth Conference Neural Networks and Soft Computing June 6–10, 2000 Zakopane, Poland
   Google Scholar
• Mendyk A Jachowicz R Unified methodology of neural analysis in decision support systems built for pharmaceutical technology Expert Syst Appl 2007 32 1124 1131
   Web of Science ®Google Scholar
• Żurada JM Malinowski A Usui S Perturbation method for deleting redundant inputs of perceptron networks Neurocomputing 1997 14 177 193
   Web of Science ®Google Scholar
• g3data. [homepage on the Internet] g3data software for extracting data from graphs Available from: http://www.frantz.f/software/g3data.php Accessed December 6, 2012
   Google Scholar
• Kortejärvi H Malkki J Marvola M Level A in vitro-in vivo correlation (IVIVC) model with Bayesian approach to formulation series J Pharm Sci 2006 95 1595 1605 16732564
   PubMed Web of Science ®Google Scholar
• Kortejärvi H Mikkola J Bäckman M Antila S Marvola M Development of level A, B and C in vitro-in vivo correlations for modified-release levosimendan capsules Int J Pharm 2002 241 87 95 12086724
   PubMed Web of Science ®Google Scholar
• Rossi RC Dias CL Donato EM Development and validation of dissolution test for ritonavir soft gelatin capsules based on in vivo data Int J Pharm 2007 338 119 124 17343999
   PubMed Web of Science ®Google Scholar
• Sunesen VH Vedelsdal R Kristensen HG Christrup L Müllertz A Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug Eur J Pharm Sci 2005 24 297 303 15734296
   PubMed Web of Science ®Google Scholar
• Eddington N Marroum P Uppoor R Hussain A Augsburger L Development and internal validation of an in vitro-in vivo correlation for a hydrophilic metoprolol tartrate extended release tablet formulation Pharm Res 1998 15 466 473 9563079
   PubMed Web of Science ®Google Scholar
• Eddington N Rekhi G Lesko L Augsburger L Scale-up effects on dissolution and bioavailability of propranolol hydrochloride and metoprolol tartrate tablet formulations AAPS Pharm Sci Tech 2000 1 a14
   Google Scholar
• Rekhi GS Eddington ND Fossler MJ Evaluation of in vitro release rate and in vivo absorption characteristics of four metoprolol tartrate immediate-release tablet formulations Pharm Dev Tech Technol 1997 2 11 24
   PubMed Web of Science ®Google Scholar
• Sirisuth N Eddington N The influence of first pass metabolism on the development and validation of an IVIVC for metoprolol extended release tablets Eur J Pharm Biopharm 2002 53 301 309 11976018
   PubMed Web of Science ®Google Scholar
• Ahmed IS Aboul-Einien MH In vitro and in vivo evaluation of a fast-disintegrating lyophilized dry emulsion tablet containing griseofulvin Eur J Pharm Sci 2007 32 58 68 17628451
   PubMed Web of Science ®Google Scholar
• Korhonen O Kanerva H Vidgren M Urtti A Ketolainen J Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers J Control Release 2004 95 515 520 15023462
   PubMed Web of Science ®Google Scholar
• Mahaguna V Talbert R Peters J Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam Eur J Pharm Biopharm 2003 56 461 468 14602191
   PubMed Web of Science ®Google Scholar
• Roda A Sabatini L Mirasoli M Baraldini M Roda E Bioavailability of a new ketoprofen formulation for once-daily oral administration Int J Pharm 2002 241 165 172 12086732
   PubMed Web of Science ®Google Scholar
• Rani M Mishra B Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium AAPS Pharm Sci Tech 2004 5 153 159
   Web of Science ®Google Scholar
• Jung H Milán R Girard M León F Montoya M Bioequivalence study of carbamazepine tablets, in vitro/in vivo correlation Int J Pharm 1997 152 37 44
   Web of Science ®Google Scholar
• Honkanen O Pia L Janne M Bioavailability and in vitro oesophageal sticking tendency of hydroxypropyl methylcellulose capsule formulations and corresponding gelatine capsule formulations Eur J Pharm Sci 2002 15 479 488 12036724
   PubMed Web of Science ®Google Scholar
• Nykänen P Lempää S Aaltonen M Citric acid as excipient in multiple-unit enteric-coated tablets for targeting drugs on the colon Int J Pharm 2001 229 155 162 11604268
   PubMed Web of Science ®Google Scholar
• Hayashi T Kanbe H Okada M In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets Int J Pharm 2007 341 105 113 17512147
   PubMed Web of Science ®Google Scholar
• Zaid AN Natour S Qaddomi A Abu Ghoush A Formulation and in vitro and in vivo evaluation of film coated montelukast sodium tablets using Opadry yellow 20A82938 on an industrial scale Drug Des Devel Ther 2013 7 25 31
   Web of Science ®Google Scholar